Journal
AMERICAN JOURNAL OF HUMAN GENETICS
Volume 96, Issue 6, Pages 1001-1007Publisher
CELL PRESS
DOI: 10.1016/j.ajhg.2015.04.022
Keywords
-
Categories
Funding
- Ministry of Health, Labor and Welfare of Japan
- Grants-in-Aid for Scientific Research [26290047, 26253061, 26640091, 26310106, 26830128] Funding Source: KAKEN
Ask authors/readers for more resources
Fanconi anemia (FA) is a rare genetic disorder characterized by genome instability, increased cancer susceptibility, progressive bone marrow failure (BMF), and various developmental abnormalities resulting from the defective FA pathway. FA is caused by mutations in genes that mediate repair processes of interstrand crosslinks and/or DNA adducts generated by endogenous aldehydes. The UBE2T E2 ubiquitin conjugating enzyme acts in FANCD2/FANCI monoubiquitination, a critical event in the pathway. Here we identified two unrelated FA-affected individuals, each harboring biallelic mutations in UBE2T. They both produced a defective UBE2T protein with the same missense alteration (p.Gln2Glu) that abolished FANCD2 monoubiquitination and interaction with FANCL. We suggest this FA complementation group be named FA-T.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available